Skip to main content

Table 2 Mortality at 30 days

From: Can minimally invasive puncture and drainage for hypertensive spontaneous Basal Ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study

 

All Patients n (%)

Groups

    

A, n = 84 (%)

 

B, n = 114 (%)

  
 

Dead (GOS = 1)

Survival GOS > 1)

P

Dead (GOS = 1)

Survival GOS > 1)

Total

Dead (GOS = 1)

Survival (GOS > 1)

Total

P

Total

64 (32.3)

134 (67.7)

 

23 (27.4)

61 (72.6)

84

41 (36.0)

73 (64.0)

114

0.203

Age

         

0.203

60

42 (32.3)

88 (67.7)

0.995

9 (20.0)

36 (80.0)

45

33 (38.8)

52 (61.2)

85

0.030

 > 60

22 (32.4)

46 (67.6)

14 (35.9)

25 (64.1)

39

8 (27.6)

21 (72.4)

29

0.472

Gender

         

0.203

 Female

14 (25.9)

40 (74.1)

0.240

4 (18.2)

18 (81.8)

22

10 (31.3)

22 (68.8)

32

0.286

 Male

50 (34.7)

94 (65.3)

19 (30.6)

43 (69.4)

62

31 (37.8)

51 (62.2)

82

0.373

Diabetes

         

0.203

 No

34 (26.8)

93 (73.2)

0.026

12 (20.0)

48 (80.0)

60

22 (32.8)

45 (67.2)

67

0.104

 Yes

30 (42.3)

41 (57.7)

11 (45.8)

13 (54.2)

24

19 (40.4)

28 (59.6)

47

0.665

GCS

  

<0.001

      

0221

 15-13 grade 1

2 (6.7)

28 (93.3)

 

0 (0.0)

17 (100.0)

17

2 (15.4)

11 (84.6)

13

0.179

 12-7 grade 2

21 (23.9)

67 (76.1)

0.059a

7 (18.9)

30 (81.1)

37

14 (27.5)

37 (72.5)

51

0.357

 6-3 grade 3

41 (51.3)

39 (48.8)

<0.001b

16 (53.3)

14 (46.7)

30

25 (50.0)

25 (50.0)

50

0.477

NIHSS

  

0.001

      

0.221

 <15 grade 1

5 (15.6)

27 (84.4)

 

0 (0.0)

17 (100)

17

5 (33.3)

10 (66.7)

15

0.015

 15-20 grade 2

9 (18.0)

41 (82.0)

1.000.a

3 (13.6)

19 (86.4)

22

6 (21.4)

22 (78.6)

28

0.713

 >20 grade 3

50 (43.1)

66 (56.9)

0.002b

20 (44.4)

25 (55.6)

45

30 (42.3)

41 (55.7)

71

0.817

HV, mL

         

0.203

60

29 (22.1)

102 (77.9)

<0.001

8 (13.1)

53 (86.9)

61

21 (30.0)

49 (70.0)

70

0.021

 > 60

35 (52.5)

32 (47.8)

15 (65.2)

8 (34.8)

23

20 (45.5)

24 (54.5)

44

0.127

IVH

  

<0.001

      

0.221

 0

12 (18.8)

52 (81.3)

 

3 (10.0)

27 (90.0)

30

9 (26.5)

25 (73.5)

34

0.117

 1-4 grade 1

10 (16.1)

52 (83.9)

0.816c

3 (11.1)

24 (88.9)

27

7 (20.0)

28 (80.0)

35

0.491

 5-8 grade 2

19 (52.8)

17 (47.2)

<0.001a

6 (40.0)

9 (60.0)

15

13 (61.9)

8 (38.1)

21

0.201

 9-12 grade 3

23 (63.9)

13 (36.1)

0.471b

11 (91.7)

1 (8.3)

12

12 (50.0)

12 (50.0)

24

0.025

Complications, n (%)

         

RB

         

0.221

  No

57 (30.2)

132 (69.8)

0.006

22 (26.5)

61 (73.5)

83

35 (33.0)

71 (67.0)

106

0.334

  Yes

7 (77.8)

2 (22.2)

1 (100)

0 (0.0)

1

6 (75.0)

2 (25.0)

8

1.000

RF

         

0.221

  NO

50 (28.2)

127 (71.8)

0.001

19 (24.1)

60 (75.9)

79

31 (31.6)

67 (68.4)

98

0.267

  Yes

14 (66.7)

7 (33.3)

4 (80.0)

1 (20.0)

5

10 (62.5)

6 (37.5)

16

0.624

PI

         

0.203

  No

31 (26.7)

85 (73.3)

0.046

12 (24.0)

38 (76.0)

50

19 (28.8)

47 (71.2)

66

0.566

  Yes

33 (40.2)

49 (59.8)

11 (32.4)

23 (67.6)

34

22 (45.8)

26 (54.2)

48

0.223

UGB

         

0.221

  No

56 (30.6)

127 (69.4)

0.087

19 (24.7)

58 (75.3)

77

37 (34.9)

69 (65.1)

106

0.139

  Yes

8 (53.3)

7 (46.7)

4 (57.1)

3 (42.9)

7

4 (50.0)

4 (50.0)

8

1.000

  1. P values were calculated using the Wilcoxon or Kruskal-Wallis rank sum tests. Groups: A, minimal invasive puncture and drainage; B, decompressive craniectomy; GOS: Glasgow Outcome Scale; BP: blood pressure; SPB systolic blood pressure. DBP: diastolic blood pressure. GCS: Glasgow Coma Scale; NIHSS: National Institutes of Health Stroke Scale; HV: hematoma volume; IVH: intraventricular hemorrhage; RB: rebleed; PI: pulmonary infection; RF: renal failure; UGB: upper gastrointestinal bleeding; agrade 1 vs. grade 2; bgrade 2 vs. grade 3; cIVH 0 vs. IVH grade 1.